Navigation Links
Zeus: Dedicated to Advancing Biomaterial Technology with Enhanced Capabilities
Date:9/30/2009

ORANGEBURG, S.C., Sept. 30 /PRNewswire/ -- Zeus Inc., a global leader in material science and the manufacture of fluoropolymer tubing, announces its new state-of-the-art advanced materials laboratory dedicated exclusively to the extrusion, analysis, and characterization of Absorv(TM) Bioabsorbables. Zeus has also expanded its Absorv Bioabsorbables capabilities, including precision tubing ranging from outer diameters of 0.012in to 0.250in and tolerances as tight as +\- 0.0005in.

"Zeus has a history of being at the forefront of cutting-edge technology in polymer science and we are continuing that tradition in the field of absorbable materials," said Dr. Bruce Anneaux, Corporate Manager, Research & Development. "We have devoted an entirely new area to the development of bioabsorbables as these polymers will play a significant role in modern medical device design and next-generation therapies."

Zeus has dedicated 5,000 sq ft of laboratory space for the exploration and production of Absorv Bioabsorbables. The new facility is a controlled environment with an integral Class V clean room. The laboratory is staffed with a team of leading scientists, engineers, and technicians who are highly skilled and experienced in the field of biomaterial development. Laboratory staff also includes regulatory engineers and quality control personnel who are working to pursue new certification levels.

"Not only have we expanded our facilities and technical staff, but we have also designated a portion of our sales force to work solely with our partners in the field of bioabsorbables. Zeus has seen tremendous response to initial efforts within this field and it quickly became apparent we needed specific focus on this emerging product line," said Josh Ridley, Business Development Manager - Biomaterials. "Our goal is to help companies expand or improve their standard offerings through new processing and product forms."

Enhanced properties of Absorv Bioabsorbables include modulated degradation rates, varying strengths and stiffness, and FDA approval for medical devices. Zeus is currently processing these materials and providing multiple extrusion forms, such as shapes, special profiles, and multi-lumens. The product offering also includes precision tubing ranging from outer diameters of 0.012in to 0.250in and tolerances as tight as +\- 0.0005in; monofilament ranging from diameters of 0.003in to 0.060in; tape/ribbon; rod stock; and compounded pellet form. Zeus also provides absorbable polymers as cast films and non-woven microporous sheets.

About Zeus, Inc.:

Zeus, Inc. is headquartered in Orangeburg, SC USA. Zeus is a world leader in material science and the production of high-performance polymer tubing used in demanding applications, operating multiple facilities in North America and internationally. Zeus products and services are preferred by companies in medical, automotive, electrical, fluid handling and mechanical markets. For more information, visit http://www.zeusinc.com.

    Press Contact:

    Samantha Farlow
    Communications Coordinator
    (803) 268-9500
    publicrelations@zeusinc.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE Zeus, Inc.


'/>"/>
SOURCE Zeus, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. UCSF and YouTube Launch Channel Dedicated to Educating the Public About Neurodegenerative Diseases
2. First Seed Sales of Dedicated Energy Crops Begin
3. Neurosurgery Journal Issues Supplement Dedicated to CyberKnife Radiosurgery Experience
4. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
5. American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health
6. International Society for Stem Cell Research Applauds Outcome of Proposal 2 Advancing Stem Cell Research
7. CFSO Calls for Roundtable to Develop National Strategy for Advancing Forensic Sciences in the United States
8. Nuclear fusion research key to advancing computer chips
9. National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications
10. National Stem Cell Holding in Final Stage Negotiations for Exclusive Licensing of its Recently Discovered Biomaterial for Anti-Aging Applications
11. LeMaitre Vascular Acquires Biomateriali, a Vascular Graft Manufacturer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... , June 23, 2016 A person commits ... the crime scene to track the criminal down. ... U.S. Food and Drug Administration (FDA) uses DNA evidence to ... Sound far-fetched? It,s not. The FDA has ... to support investigations of foodborne illnesses. Put as simply as ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
Breaking Biology Technology:
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
Breaking Biology News(10 mins):